Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement

18 Jul 2018 07:00

RNS Number : 9392U
Renold PLC
18 July 2018
 

Renold plc

 

("Renold", "the Company" or "the Group")

 

AGM Statement

 

18 July 2018

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing, ahead of its Annual General Meeting to be held at 11:00am today, the following statement in respect of the first quarter of the financial year ending 31 March 2019 ('the Quarter').

 

The Quarter saw overall Group performance in line with expectations. Improving order intake in the second half of the previous year was converted into growth in underlying1 revenue in the Quarter of 3.7%, compared to the first quarter of the prior year. Higher sales are being delivered in both divisions, with underlying revenue ahead by 3.1% for Chain and 4.9% for Torque Transmission.

 

The trend of orders growing at a faster rate than revenue has continued into the early part of the new financial year, with order intake in the Quarter 9.2% ahead of revenue in the same period (book to bill ratio). Underlying order intake was 12% higher than in the first quarter of the prior year (excluding the major multi-year project win by UK Couplings in June 2017).

 

Progress continues to be made in building our new Chinese chain factory, with construction nearing completion. The phased transfer of manufacturing operations will be undertaken over the coming months, with full operation from the new facility scheduled for the end of the financial year.

 

The Group remains on track to deliver a result for the full year in line with the Board's expectations.

 

Robert Purcell, Chief Executive of Renold, said:

"Strong order intake in the latter part of the prior year supported growing revenues in the Quarter across most of our geographic regions, with the Americas particularly strong in both the Chain and Torque Transmission divisions.

 

"Continued revenue growth provides the platform for margin improvement supported by continued progress in delivering against our strategic plan."

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by re-translating the prior year comparative figures to the current year exchange rate.

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Ian Scapens, Group Finance Director

 

 

 

Arden Partners

020 7614 5917

Chris Hardie

 

Ben Cryer

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Helen Tarbet

Rosie Driscoll

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSFWFIWFASEDW
Date   Source Headline
14th Nov 20187:00 amRNSHalf-year Report
11th Oct 20187:00 amRNSTrading Update
2nd Oct 20187:00 amRNSAppointment of Broker
2nd Aug 20189:00 amRNSBlock listing Interim Review
18th Jul 20181:26 pmRNSResult of AGM
18th Jul 20187:00 amRNSAGM Statement
14th Jun 20182:09 pmRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAnnual Report and Accounts
8th Jun 201812:49 pmRNSGrant of Awards - Performance Share Plan
31st May 20182:54 pmRNSDirector/PDMR Shareholding
31st May 20182:46 pmRNSDirector/PDMR Shareholding
31st May 201810:05 amRNSDirector/PDMR Shareholding
31st May 20188:47 amRNSDirector/PDMR Shareholding
30th May 20188:38 amRNSDirector/PDMR Shareholding
29th May 20187:00 amRNSFinal Results
25th Apr 201810:07 amRNSHolding(s) in Company
24th Apr 201810:06 amRNSHolding(s) in Company
20th Apr 20187:00 amRNSNotice of Results
19th Apr 20183:16 pmRNSHolding(s) in Company
19th Apr 20188:41 amRNSHolding(s) in Company
18th Apr 20189:02 amRNSHolding(s) in Company
10th Apr 20189:55 amRNSHolding(s) in Company
9th Apr 201810:21 amRNSHolding(s) in Company
3rd Apr 201810:46 amRNSHolding(s) in Company
9th Mar 20187:00 amRNSTrading Update
6th Feb 20184:35 pmRNSPrice Monitoring Extension
2nd Feb 20188:00 amRNSBlock listing Interim Review
14th Nov 20177:00 amRNSHalf-year Report
26th Oct 20173:07 pmRNSHolding(s) in Company
12th Oct 20177:00 amRNSTrading Update
4th Oct 20173:11 pmRNSHolding(s) in Company
10th Aug 20175:16 pmRNSDirector Declaration
1st Aug 201711:37 amRNSBlock listing Interim Review
19th Jul 201712:29 pmRNSResult of AGM
19th Jul 20177:00 amRNSAGM Statement
14th Jul 201711:14 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSAnnual Report and Accounts
7th Jun 20172:26 pmRNSGrant of Awards - Performance Share Plan
2nd Jun 20174:40 pmRNSHolding(s) in Company
30th May 20177:00 amRNSFinal Results
4th May 201711:00 amRNSHolding(s) in Company
28th Apr 201710:39 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSNotification of Investor Visit
18th Apr 20171:21 pmRNSHolding(s) in Company
13th Apr 201710:35 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSTrading Update
2nd Feb 20173:32 pmRNSBlock listing Interim Review
19th Jan 20173:08 pmRNSGrant of Awards - Performance Share Plan
9th Jan 20177:00 amRNSAppointment of Non-Executive Director
22nd Dec 20167:00 amRNSStrategic Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.